From what I have read, it would appear that tests have found H1N1 to be resistant to Tamiflu, otherwise known as Oseltamivir.
The data I have found is quite an astonishing read.. Firstly I will provide a bit of info into a few other related items that I stumbled upon whilst
searching for the info I was after.
Firstly it would seem that the H1N1 virus originates all from one source...
Two influenza A viruses were isolated from pigs in Thailand in January 1988 during the early febrile stage of an influenza-like illness. The isolates
contained hemagglutinin and neuraminidase antigens related to those of swine H1N1 influenza virus. This result based on the virus isolation is
compatible with the epizootiological evidence that, unlike the human influenza with peak activity in summer (May–July), swine influenza virus is
prevalent in the winter season (November–January) in Thailand. suggesting that they may be of the same origin.
Please note the difference of infection periods between human and swine virus.
So it popped up in Thailand in 1988 and then in Korea, but with a North American connection..
A swine influenza H1N1 virus was isolated from a pig during a severe outbreak of respiratory disease in Korea. All genes of the H1N1 isolate,
including hemagglutinin (HA), neuraminidase (NA), matrix (M), nucleoprotein (NP), non-structural (NS), PA, PB1 and PB2, were of swine origin. Also,
all these genes showed a close phylogenic relationship with those of H1N1 viruses previously isolated from pigs in the United States. These results
suggest that North American swine influenza virus has actually been transmitted to pigs in Korea.
So now we come down to the hard core studies. This particular study makes fascinating reading and really opened my eyes up a lot about this flu virus.
It would appear we are being fed yet another huge amount of propaganda and lies in order to turn a profit.
In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the
epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007–08
season for resistance. Questionnaires from physicians provided information on predisposing diseases, oseltamivir use, symptoms, and complications.
Clinical data were obtained for 265 patients. In total, 183 (67.3%) of 272 viruses were oseltamivir resistant. Resistance was not associated with
prior use of antiviral drugs. Symptoms and hospitalization rates did not differ for patients infected with a resistant or a susceptible virus.
Oseltamivir-resistant influenza viruses A (H1N1) did not show diminished capability to spread in the absence of selective pressure. The ability of
these viruses to sustain their fitness and spread among persons should be considered when shaping future strategies for treating and preventing
seasonal and pandemic influenza.
Don't that just knock you for six? I was stunned when I read that. There is a whole lot more info on this from the same source and is quite an
Further important snippets of info are these,
The influenza virus neuraminidase inhibitors zanamivir and oseltamivir were introduced into clinical practice in various parts of the world from 1999
through 2002 (1). Oseltamivir limits replication of both influenza A and B viruses (1). In most European countries, neuraminidase inhibitors are not
widely used to treat seasonal influenza, but they are being stockpiled in many countries as part of their pandemic influenza preparedness.
Pandemic preparedness??? Was someone expecting something to happen this year..
Don't forget to look at the date of this publication.. February 2009...
the Norwegian national influenza center and at the Health Protection Agency confirmed the high proportion of oseltamivir resistance. This unexpected
and unprecedented discovery had possible public health implications of international concern. On January 25, 2008, the Norwegian Institute of Public
Health notified WHO of these findings under the International Health Regulations (6) and notified the European Commission through the Early Warning
and Response System. The Institute also informed hospitals and physicians in Norway about a possible lack of therapeutic effect when treating patients
with oseltamivir. By the end of January, oseltamivir-resistant viruses had been reported from several European countries (7).
Are we about to witness a global pandemic the likes of which have never been seen?
Although there are reports that this particular strain of H1N1 is not as deadly a some believe it to be, there is the possibility it could mutate or
pick up parts of other viruses and become so deadly that it kills within hours.
Now, it does appear that other symptoms which can and do cause death are elaready known to be caused by H1N1;
Of 241 patients, 58 (24.1%) had >1 complications recorded, but no difference was observed between those infected with a resistant virus and those
infected with a susceptible virus (Table 2). Bronchitis and pneumonia were the most frequent complications, reported for 22 and 17 patients,
respectively. The age of the 17 patients who had pneumonia ranged from 8 months to 65 years (mean 29 years): 2 (12.5%) were 0–4 years of age, 5
(31.3%) were 5–14 years of age, 2 (12.5%) were 15–24 years of age, 4 (25.0%) were 25–59 years of age, and 3 (18.8%) were >59 years of age. Of
the 17 patients with pneumonia, 15 were infected with a resistant virus.
It just makes you want to scream and shout.. this report is astonishing and it seems it has been brushed under the carpet for some reason.. And I feel
that this reason is so that those with share in Tamiflu make a profit.
mod edit, fix link
[edit on 2-5-2009 by DontTreadOnMe]